BioLingus (Cayman) Limited (SUBL)

BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.

IPO Price

$20.00

Shares Offered

360,000

Deal Size

$7.20M

SUBL Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Total Valuation

Year Ending	Current	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Capitalization	222	-	-
Market Cap Growth	-	-	-
Enterprise Value	229	-	-

Year Ending	Current	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Debt / Equity Ratio	-0.83	-0.87	-0.83
Net Debt / Equity Ratio	-0.82	-0.84	-0.79
Quick Ratio	0.01	0.04	0.05
Interest Coverage	-1.69	-6.10	-17.52
Return on Assets (ROA)	-	-397.82%	-272.87%
Return on Capital Employed (ROCE)	5.47%	23.59%	49.01%